Warning: This article has not yet been accepted for publication by a peer reviewed journal. It is presented here mainly for the benefit of fellow researchers. Casual readers should not act on its findings, and journalists should be wary of reporting them.
clinmed/2004110001v1 (February 28, 2005)
Contact author(s) for copyright information
USAGE OF ILOPROST IN VASCULO-BEHCET'S DISEASE
Case Report and Literature Review
Murat Ozeren, Pelin Durmazlar, and Ertan Yucel
Background: Vasculo-Behcet's disease is a rare but serious form of the disease and carries a poor prognosis. Here we are presenting first time successful results of iloprost in a VBD to prevent the patient from the catastrophic results of surgery.
Patient and method: A 34 year old male patient with arterial involvement due to Vasculo-Behcet's disease was hospitalized. Iloprost treatment was planned to the patient because of his previous vascular operations and high recurrence rate of surgery in Behcet?s disease.
Conclusion: Iloprost is a safe and promising drug for the treatment of Vasculo-Behcet's disease with arterial involvement and also we are recommending that iloprost can be used as an alternative first line medical treatment.